Skip to main content
. 2023 Jan 5;14:1037904. doi: 10.3389/fnagi.2022.1037904

Table 5.

Incidence of mild and severe decline in each neuropsychological test in different groups.

Incidence of mild and severe decline, No./Total (%) Mild decline Major decline
Placebo (n = 51) Probiotics (n = 45) P-value Placebo (n = 51) Probiotics (n = 45) P-value
HVLT-R 17/51 (33.3) 5/45 (11.1) 0.01* 2/51 (3.9) 1/45 (2.2) 1.000
HVLT-R delayed recall test 20/51 (39.2) 6/45 (13.3) 0.004** 0 0
HVLT-R discrimination index 8/51 (15.7) 3/45 (6.7) 0.166 9/51 (17.6) 1/45 (2.2) 0.018*
BVMT-R 6/51 (11.8) 5/45 (11.1) 0.920 0 0
BVMT-R delayed recall test 9/51 (17.6) 7/45 (15.6) 0.784 1/51 (2.0) 1/45 (2.2) 1.000
BVLT-R discrimination index 6/51 (11.8) 4/45 (8.9) 0.746 5/51 (9.8) 3/45 (6.7) 0.719
Number connection test 0 1/45 (2.2) 0.469 0 0
Benton judgment of line orientation 9/51 (17.6) 7/45 (15.6) 0.784 1/51 (2.0) 0 1.000
Digit span test total 4/51 (7.8) 3/45 (6.7) 1.000 1/51 (2.0) 1/45 (2.2) 1.000
Digit symbol substitution test 4/51 (7.8) 2/45 (4.4) 0.681 0 0
Verbal fluency test 6/51 (11.8) 6/45 (13.3) 0.817 5/51 (9.8) 0 0.058

HVLT-R, Hopkins verbal learning test-revised; BVMT-R, brief visuospatial memory test-revised. All data are presented as number (%), median (first quartile, third quartile), or mean ± SD; *p < 0.5, **p < 0.01.